ADP-A2M4 Shows Early Promising Clinical Activity in Synovial Sarcoma

Brian A. Van Tine, MD, PhD, discusses the results of a phase I study looking at the effects of ADP-A2M4 in patients with synovial sarcoma.

Read the full article here

Related Articles